France Metagenomics Market Size & Outlook, 2023-2030
France metagenomics market, 2018-2030 (US$M)
Related Markets
France metagenomics market highlights
- The France metagenomics market generated a revenue of USD 83.1 million in 2023 and is expected to reach USD 200.3 million by 2030.
- The France market is expected to grow at a CAGR of 13.4% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 83.1 million |
| Market revenue in 2030 | USD 200.3 million |
| Growth rate | 13.4% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, France accounted for 4.1% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 251.6 million by 2030.
Kits & reagents was the largest segment with a revenue share of 61.49% in 2023. Horizon Databook has segmented the France metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of France metagenomics market can primarily be attributed to extensive government initiatives that are boosting the adoption of NGS solutions in the country. Since 2013, the French National Cancer Institute (INCa) has supported the implementation of targeted NGS as part of routine clinical practice. In addition, France implemented a national plan, the 2025 France Genomic Medicine Initiative, to ensure adequate access to genomic medicine for all patients.
This initiative is dedicated to introducing genome sequencing to the care pathway. A strong presence of well-established and emerging metagenomics product manufacturers and continuous organic & inorganic growth strategies they adopt are expected to support the market. In February 2020, Scipio Bioscience, a French startup, raised around USD 6.8 million (EUR 6 million) in a Series A round to develop cost-effective single-cell RNA sequencing kits.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France metagenomics market size, by product, 2018-2030 (US$M)
France Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
